Skip to main content
Scythene
← Back to all posts

November 17, 2026 · Nelson Marques, RD, CSSD

Saw Palmetto: 85-to-95 Percent Free Fatty Acids or It Is Not the Serenoa Repens the Studies Used

The saw palmetto category sells a 320 mg front-label number that hides whether the capsule carries the lipidosterolic extract the Permixon and SabalSelect trials ran on or a powdered-berry fill that delivers roughly a tenth of the active-fraction dose. The published human literature on prostate-health outcomes sits almost entirely on 85-to-95 percent free-fatty-acid-standardized lipidosterolic extracts at 320 mg per day. The powdered-berry capsule at the same 320 mg front-label number carries roughly 8-to-15 percent free fatty acids by weight. Same number on the label, 6-to-11-fold difference in active-fraction dose. Here is how the Serenoa repens category is structured, what the extraction and standardization really mean, which branded extracts carry the trial literature, the proprietary-blend problem that hides the extraction grade, and the four-question Supplement Facts read that separates the trial-anchored material from the powdered-berry fill.

#saw-palmetto#forms#standardization#labels#mens-health#supplement-science

Saw Palmetto: 85-to-95 Percent Free Fatty Acids or It Is Not the Serenoa Repens the Studies Used

Walk the men's-health aisle and the saw palmetto row reads like a single ingredient. Every bottle lists a number — 160 mg, 320 mg, 500 mg — and the buyer compares by that number. The category sits on two structurally different ingredients that the front-label milligram number treats as interchangeable and the clinical-trial literature does not.

The published human literature on saw palmetto for lower urinary tract symptoms and benign prostatic hyperplasia-related measures runs almost entirely on one specific thing: a lipidosterolic extract of Serenoa repens fruit, standardized to 85-to-95 percent free fatty acids and phytosterols, dosed at 320 mg per day either as a single dose or split as 160 mg twice daily. Permixon, SabalSelect, and a handful of other branded extracts are the materials the Wilt 2002 Cochrane review, the Barry 2011 CAMUS trial, the MacDonald 2012 and Tacklind 2012 updates, and most of the European urology-society-cited positive trials actually used.

The powdered-berry capsule that says "Saw Palmetto 320 mg" on the front label and nothing else on the back is a different ingredient. Powdered dried fruit carries roughly 8-to-15 percent free fatty acids by weight. Two capsules of the same 320 mg front-label number — one carrying 85-to-95 percent FFA standardization, the other carrying raw-fruit powder — differ in the active-fraction dose by a factor of six to eleven.

This is the same pattern that runs through the clinically studied ingredient versus clinically studied dose problem, the proprietary blends underdosing problem, and the 60-second supplement label read: the front-label number is not the same thing as the active-form dose the body sees.

What the Active Fraction Actually Is

Serenoa repens fruit contains a mixture of fatty acids (lauric, myristic, oleic, palmitic, linoleic), phytosterols (beta-sitosterol, campesterol, stigmasterol), long-chain alcohols, and flavonoids. The pharmacologically active fraction — the one the published mechanisms-of-action work pins the outcomes on — is the free fatty acid and phytosterol combination, not the fiber or the water-soluble polysaccharide fraction of the raw fruit.

The lipidosterolic extraction concentrates that active fraction. The two extraction methods the trial-anchored branded materials use are hexane extraction (Permixon) and supercritical CO2 extraction (SabalSelect, Prostaserene, and several others). Both methods pull the lipid-soluble fraction out of the dried fruit and leave the water-soluble carbohydrate and fiber behind. The resulting extract runs 85-to-95 percent free fatty acids and 0.2-to-0.4 percent total phytosterols by weight. That is the composition the Supplement Facts panel discloses on a trial-anchored product.

A capsule that lists "Saw Palmetto Berry Powder 320 mg" or "Saw Palmetto Fruit 320 mg" is not that extract. It is dried, milled fruit packed into a capsule. Chemically it contains the same fatty acids and phytosterols, but at the 8-to-15 percent of the raw fruit weight concentration. You would need roughly 2 to 3 grams of raw-fruit powder to deliver the same active-fraction dose the 320 mg lipidosterolic extract delivers. Nobody is filling three capsules a day of powdered berry to hit that math; the raw-fruit product is simply under-dosed.

The IU-Free Label Trap

Unlike vitamin A or vitamin D, saw palmetto has no established daily value, no IU equivalent, and no required-label unit beyond the milligram weight of the capsule contents. That means the label is required to disclose how much of what is in the capsule but is not required to disclose the extraction grade in plain terms. The compliant minimum is often a two-line entry on the Supplement Facts panel that reads:

Saw Palmetto Extract (fruit) 320 mg

That line is compliant whether the extract is 85 percent free fatty acids or 15 percent. Unless the line continues with "(standardized to 85-to-95 percent free fatty acids)" or "(lipidosterolic extract, 85-to-95% FFA)" or the branded raw material is named ("Permixon," "SabalSelect"), the label has disclosed nothing that separates the trial-anchored material from the under-dosed fill.

The trial-anchored brands disclose. The commodity-shelf brands do not. A supplement-literate buyer treats the absence of the standardization as the answer — if it were 85-to-95 percent FFA, the label would say so, because that is the specification the retailer pays a premium for and the brand uses as a selling point.

What the Four Branded Extracts Are

The handful of branded raw materials that carry essentially all the human outcome literature:

  • Permixon (Pierre Fabre, hexane-extracted) — the single most-trial-cited lipidosterolic extract. 85-to-95 percent free fatty acids. 320 mg once-daily trial dosing in most of the European urology literature.
  • SabalSelect (Indena, supercritical CO2-extracted) — the second most-trial-cited. 85-to-95 percent FFA. Standardized phytosterol fraction also disclosed.
  • Prostaserene / Saballin (various European manufacturers, supercritical CO2 or ethanol-extracted) — appears in several of the European trials. Specification varies by manufacturer, check the certificate of analysis.
  • US Pharmacopeia-grade saw palmetto extract — the USP monograph for saw palmetto extract specifies a not-less-than-80.5-percent total fatty acid content. A product that discloses "USP grade" and names the FFA percentage is at least inside the trial-anchored range.

A label that names one of these branded raw materials, or that specifies the standardization percentage on the Supplement Facts line, is disclosing what the trial literature was built on. A label that says only "Saw Palmetto 320 mg" is not.

The Proprietary-Blend Problem

The men's-health prostate-support category has a proprietary-blend problem the vitamins-and-minerals aisle does not, because the whole category is built on what are effectively three or four ingredients the trial literature actually supports. A typical prostate-support formula front-label-promises a 1,500-to-2,500 mg "Men's Prostate Blend" that contains, in unknown per-ingredient weights, the following:

Saw Palmetto Extract, Pygeum Africanum Bark Extract, Pumpkin Seed Extract, Stinging Nettle Root, Lycopene, Zinc, Beta-Sitosterol Complex, Quercetin, and Cranberry Extract — all buried in a single proprietary blend weight.

NOTE

The problem is double. First, the saw palmetto dose is unknowable — it could be 50 mg or 300 mg of the 2,000 mg blend. Second, even if it is 320 mg, there is no way to tell from the label whether it is the 85-to-95 percent FFA lipidosterolic extract or the 10 percent raw-fruit powder. A reader cannot audit either the dose or the grade.

The clean product discloses the saw palmetto separately — its own line, with its own weight, with its own standardization percentage or branded raw material name. Pygeum, pumpkin seed oil, nettle root, lycopene, and zinc belong on their own lines too, each with its own standardization. The proprietary blend is where the underdosing and the grade-ambiguity hide.

The Price Signal

The commercial reality: a lipidosterolic saw palmetto extract standardized to 85-to-95 percent FFA costs roughly 3-to-5 times per kilogram of the raw-fruit powder. A 60-count bottle of standardized Permixon or SabalSelect material tends to retail at 20-to-35 dollars for a one-month supply. A 60-count bottle of "Saw Palmetto 320 mg" raw-fruit powder tends to retail at 6-to-12 dollars. If the retail price looks too low to be the standardized extract, it almost certainly is not.

This is not a universal rule — some of the trial-anchored raw materials have come off patent in the last decade and the pricing has compressed — but a 6-to-11-fold difference in active-fraction dose does not disappear into a 2-dollar retail-price delta.

The 20-Second Supplement Facts Read

Before buying a saw palmetto product, scan the Supplement Facts panel for four things:

  1. Is the extract standardized? The line that discloses saw palmetto must specify "standardized to 85-to-95% free fatty acids," name a branded raw material (Permixon, SabalSelect, Prostaserene), or carry a USP-grade designation. If it says only "Saw Palmetto 320 mg" or "Saw Palmetto Berry Powder 320 mg," treat it as under-dosed.
  2. Is the per-serving dose at or above 320 mg? The trial dose is 320 mg per day, split or once-daily. A product that delivers less than 320 mg per serving without a split-dose instruction on the label is below the anchored dose.
  3. Is it a standalone line, not a proprietary blend? The saw palmetto weight must be its own number, not rolled into a "Prostate Health Blend." A blend that lists saw palmetto first can still be delivering 50 mg of it against the 320 mg anchored dose.
  4. Is the extraction method disclosed? Hexane-extracted, supercritical CO2-extracted, or ethanol-extracted all produce trial-anchored material at the right standardization. An undisclosed method on a non-branded raw material is a flag, not a disqualifier — but it tells you to scrutinize the standardization claim.

Two bottles on the same shelf, same front-label 320 mg number. One is Permixon lipidosterolic extract at 90 percent free fatty acids. The other is powdered dried berry at 12 percent FFA. The trial literature — and the body's prostate tissue — reads them as different products.

SUBSCRIBE

Get more like this.

Evidence-based writing on supplements, performance nutrition, and the research behind what actually works. No spam, no daily emails — just the good stuff.

Written by Nelson Marques, RD, CSSD — a registered dietitian and board certified specialist in sports dietetics with 10 years in performance nutrition. Founder of Scythene Supplements.

More about Nelson →